beta

GENE

Genetic Technologies Ltd.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

genetic technologies (asx: gtg, nasdaq global market: gene) is leading-edge genetic testing and reproductive services business which, together with an extensive range of international patents and allied research activities, aims at uncovering the impact of dna on health. throughout the asia pacific region, we translate specialised genetic tests into products and services that optimise the health knowledge and outcomes in humans, animals and plants.

Market Cap: 11.1 Million

Primary Exchange: NASDAQ

Website: https://www.gtglabs.com/

Shares Outstanding: 3.85 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.8065803892691796

Sector: Professional, Scientific, and Technical Services

Industry: Testing Laboratories

Ethical Flags

Longest drawdown: 4323 trading days

From: 2013-05-20 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-01-20 5.0 1.0 5.0
Data provided by IEX Cloud